Flagship General Partner and CEO and Co-Founder of ProFound Therapeutics, Avak Kahvejian, shares what鈥檚 inspiring about working at the boundary of human ingenuity, the importance of balancing imagination and logic, and what the future holds for ProFound鈩� in expanding the known human proteome and the possibilities for therapeutic development.
More from:
Human Health
Pioneering Partnerships: Accelerating our Collaboration with Pfizer
Unlocking Therapeutic Breakthroughs with the Power of Platform Technologies
Halting the Trajectory of Disease with Preemptive Health
AI in Action
2025 CEO Chat: Torben Straight Nissen, CEO of Repertoire Immune Medicines
